+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • ID: 4895175
  • Report
  • December 2019
  • Region: Global
  • 439 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • Calviri Inc
  • Epigenomics AG
  • Lab21 Ltd
  • Orion Genomics LLC
  • Tel Aviv University
  • MORE
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019” provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abcodia Ltd
  • Calviri Inc
  • Epigenomics AG
  • Lab21 Ltd
  • Orion Genomics LLC
  • Tel Aviv University
  • MORE
1 Introduction
1.1 Colorectal Cancer Diagnostic Tests Overview

2 Products under Development
2.1 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
2.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
2.3 Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
2.4 Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
2.5 Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials

3 Colorectal Cancer Diagnostic Tests - Pipeline Products under Development by Companies
3.1 Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
3.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development

4 Colorectal Cancer Diagnostic Tests Companies and Product Overview

5 Colorectal Cancer Diagnostic Tests - Recent Developments

6 Appendix

List of Tables
Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 10: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 13: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Veracode - Colorectal Cancer Diagnostic Tests - Product Status
Table 16: Veracode - Colorectal Cancer Diagnostic Tests - Product Description
Table 17: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status
Table 19: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description
Table 20: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Cchek - Colon Cancer Confirmatory Test - Product Status
Table 22: Cchek - Colon Cancer Confirmatory Test - Product Description
Table 23: Cchek - Colon Cancer Recurrence Test - Product Status
Table 24: Cchek - Colon Cancer Recurrence Test - Product Description
Table 25: Cchek - Colon Cancer Screening Test - Product Status
Table 26: Cchek - Colon Cancer Screening Test - Product Description
Table 27: Cchek - Colon Cancer Treatment Monitoring Test - Product Status
Table 28: Cchek - Colon Cancer Treatment Monitoring Test - Product Description
Table 29: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 30: Cchek - Colon Cancer Screening Test - Cchek Cancer Patient Efficacy Study
Table 31: Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 32: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: SimpliPro Colon-A - Product Status
Table 34: SimpliPro Colon-A - Product Description
Table 35: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status
Table 37: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description
Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Finger Stick Test - Colon Cancer - Product Status
Table 40: Finger Stick Test - Colon Cancer - Product Description
Table 41: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Status
Table 43: ArtemixRx Prognostic Test - Colon Cancer - Product Description
Table 44: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 46: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 47: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Diagnostic Test - Colorectal Adenoma - Product Status
Table 49: Diagnostic Test - Colorectal Adenoma - Product Description
Table 50: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Idylla MSI CDx - Product Status
Table 52: Idylla MSI CDx - Product Description
Table 53: Idylla MSI Test - Product Status
Table 54: Idylla MSI Test - Product Description
Table 55: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status

List of Figures
Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Abcodia Ltd
  • Almac Diagnostic Services Ltd
  • Ambergen Inc
  • ANGLE plc
  • Anixa Diagnostics Corporation
  • Applied Proteomics Inc
  • Arizona State University
  • Arrayit Corporation
  • ArtemixRx
  • Avant Diagnostics Inc
  • Bio Mark Ltd
  • Biocartis Group NV
  • Biodesix Inc
  • BioMarCare Technologies Ltd
  • BioMark Diagnostics Inc
  • BioMarker Strategies LLC
  • Biomoda Inc
  • Bioprognos SL
  • BioSystems International
  • Biotron Ltd
  • Calviri Inc
  • Castle Biosciences Inc
  • Catholic University of Leuven
  • Celcuity Inc
  • CellMax Life Inc
  • Cellmid Ltd
  • Ceres Nanosciences Inc
  • Cernostics Inc
  • ChemImage Corp
  • China Sky One Medical Inc
  • Columbia University
  • CS-Keys, Inc. (Inactive)
  • Di.V.A.L Toscana srl
  • DiagnoCure Inc. (Inactive)
  • Diazyme Laboratories Inc
  • DNAlytics SA
  • Duke University
  • EDP Biotech Corporation
  • EntreChem SL
  • Epigenomics AG
  • Eurobio Scientific SA
  • Eventus Diagnostics Inc (Inactive)
  • Exact Sciences Corp
  • Exiqon AS
  • Exosomics Siena SpA
  • Fina Biotech SL
  • Fox Chase Cancer Center
  • GenExosome Technologies Inc
  • GenomicTree Inc
  • German Cancer Research Center
  • Ghent University
  • GlycoZym
  • GoodGut SL
  • Health Discovery Corp
  • Hitachi Chemical Diagnostics Inc
  • Human Metabolome Technologies Inc
  • Ikonisys Inc
  • Institute of Molecular and Translational Medicine
  • InterGenetics Inc
  • IV Diagnostics Inc
  • Johns Hopkins University
  • King Abdullah University of Science and Technology
  • Kyo Diagnostics KK
  • Lab21 Ltd
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Leitat Technological Center
  • Lightsphere Diagnostics
  • Lineage Cell Therapeutics Inc
  • MabCure Inc
  • Master Diagnostica Sociedad Limitada
  • Matrix-Bio Inc
  • Max Delbruck Center for Molecular Medicine
  • Mayo Clinic
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Merrimack Pharmaceuticals Inc
  • Metabolon Inc
  • MetaStat Inc
  • Milagen Inc
  • Myriad Genetics Inc
  • Nanocytomics LLC
  • Norda ASA
  • Novel Bio-spectrum Technologies Inc (Inactive)
  • Nuclea Biotechnologies Inc. (Inactive)
  • Oncimmune (USA) LLC
  • Onconome, Inc. (Inactive)
  • OncoStem Diagnostics Pvt. Ltd
  • On-Q-ity, Inc. (Inactive)
  • Origin Sciences Ltd
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers Ltd
  • Oxford Gene Technology Ltd
  • PleX Diagnostics Inc (Inactive)
  • Precision Biologics Inc
  • Prediction Sciences LLC (Inactive)
  • PreMD Inc (Inactive)
  • Prescient Medicine LLC
  • Protagen AG
  • Protein Alternatives SL
  • Qiagen NV
  • Quest Diagnostics Inc
  • Rabin Medical Center
  • Rhythm Biosciences Ltd
  • RISE Life Science Corp
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene Inc
  • Shuwen Biotech Co Ltd
  • Sysmex Corp
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Treos Bio Inc
  • Trinity College Dublin
  • Universal Diagnostics SL
  • University of Illinois at Chicago
  • University of Lyon
  • University of Michigan
  • University of Notre Dame
  • University of Pittsburgh
  • University of Texas MD Anderson Cancer Center
  • University of Turku
  • University of Washington
  • University of Wisconsin Madison
  • University of Zurich
  • US Biomarkers Inc
  • vall d hebron institut de Recerca
  • Vanderbilt University
  • Vastcon Inc
  • Viomics Inc.
  • VolitionRX Ltd
  • XEPTAGEN SpA
Note: Product cover images may vary from those shown
Adroll
adroll